{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:47:14Z","timestamp":1766159234731,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007534","name":"B. Braun Melsungen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007534","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An effective testing strategy is essential for pandemic control of the novel Coronavirus disease 2019 (COVID-19) caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Breath gas analysis can expand the available toolbox for diagnostic tests by using a rapid, cost-beneficial, high-throughput point-of-care test. We conducted a bi-center clinical pilot study in Germany to evaluate breath gas analysis using multi-capillary column ion mobility spectrometry (MCC-IMS) to detect SARS-CoV-2 infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between September 23, 2020, and June 11, 2021, breath gas measurements were performed on 380 patients (SARS-CoV-2 real-time polymerase chain reaction (PCR) positive: 186; PCR negative: 194) presenting to the emergency department (ED) with respiratory symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Breath gas analysis using MCC-IMS identified 110 peaks; 54 showed statistically significant differences in peak intensity between the SARS-CoV-2 PCR-negative and PCR-positive groups. A decision tree analysis classification resulted in a sensitivity of 83% and specificity of 86%, but limited robustness to dataset changes. Modest values for the sensitivity (74%) and specificity (52%) were obtained using linear discriminant analysis. A systematic search for peaks led to a sensitivity of 77% and specificity of 67%; however, validation by transferability to other data is questionable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Despite identifying several peaks by MCC-IMS with significant differences in peak intensity between PCR-negative and PCR-positive samples, finding a classification system that allows reliable differentiation between the two groups proved to be difficult. However, with some modifications to the setup, breath gas analysis using MCC-IMS may be a useful diagnostic toolbox for SARS-CoV-2 infection.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: This study was registered at ClinicalTrials.gov on September 21, 2020 (NCT04556318; Study-ID: HC-N-H-2004).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01284-3","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:01:59Z","timestamp":1693641719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid point-of-care detection of SARS-CoV-2 infection in exhaled breath using ion mobility spectrometry: a pilot study"],"prefix":"10.1186","volume":"28","clinical-trial-number":[{"clinical-trial-number":"nct04556318","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6957-6628","authenticated-orcid":false,"given":"Florian","family":"Voit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Erber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Feuerherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bitterlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Diehl-Wiesenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gladis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Somasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. D.","family":"Spinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"1284_CR1","unstructured":"Johns Hopkins Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/. Accessed 15 Jan 2023."},{"key":"1284_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41418-020-00720-9","volume":"28","author":"G Forni","year":"2021","unstructured":"Forni G, Mantovani A, COVID-19 Commission of Accademia Nazionale dei Lincei R. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28:626\u201339. https:\/\/doi.org\/10.1038\/s41418-020-00720-9.","journal-title":"Cell Death Differ"},{"key":"1284_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2031274","author":"Q Fernandes","year":"2022","unstructured":"Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med. 2022. https:\/\/doi.org\/10.1080\/07853890.2022.2031274.","journal-title":"Ann Med"},{"key":"1284_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa816","author":"HM Rickman","year":"2020","unstructured":"Rickman HM, Rampling T, Shaw K, Martinez-Garcia G, Hail L, Coen P, et al. Nosocomial transmission of coronavirus disease 2019: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa816.","journal-title":"Clin Infect Dis"},{"key":"1284_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00875-7","author":"M Abbas","year":"2021","unstructured":"Abbas M, Robalo Nunes T, Martischang R, Zingg W, Iten A, Pittet D, et al. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control. 2021. https:\/\/doi.org\/10.1186\/s13756-020-00875-7.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1284_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1120-5","author":"MP Crotty","year":"2015","unstructured":"Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, et al. Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship. Crit Care. 2015. https:\/\/doi.org\/10.1186\/s13054-015-1120-5.","journal-title":"Crit Care"},{"key":"1284_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, Macdougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016. https:\/\/doi.org\/10.1093\/cid\/ciw118.","journal-title":"Clin Infect Dis"},{"key":"1284_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705","author":"J Dinnes","year":"2020","unstructured":"Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020. https:\/\/doi.org\/10.1002\/14651858.CD013705.","journal-title":"Cochrane Database Syst Rev"},{"key":"1284_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00461-z","author":"O Vandenberg","year":"2021","unstructured":"Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021. https:\/\/doi.org\/10.1038\/s41579-020-00461-z.","journal-title":"Nat Rev Microbiol"},{"key":"1284_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.pulmoe.2021.06.009","volume":"28","author":"R Diel","year":"2022","unstructured":"Diel R, Nienhaus A. Point-of-care COVID-19 antigen testing in German emergency rooms\u2014a cost-benefit analysis. Pulmonology. 2022;28:164\u201372. https:\/\/doi.org\/10.1016\/j.pulmoe.2021.06.009.","journal-title":"Pulmonology"},{"key":"1284_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-020-00698-8","author":"A Osterman","year":"2021","unstructured":"Osterman A, Baldauf H-M, Eletreby M, Wettengel JM, Afridi SQ, Fuchs T, et al. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol. 2021. https:\/\/doi.org\/10.1007\/s00430-020-00698-8.","journal-title":"Med Microbiol Immunol"},{"key":"1284_CR12","unstructured":"World Health Organization (WHO). Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim Guid. 2020. p. 9. https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays. Accessed 20 Nov 2020."},{"key":"1284_CR13","unstructured":"Paul-Ehrlich-Institut. Minimum criteria for rapid SARS-CoV-2 antigen tests pursuant to section 1 para 1 sentence 1 TestVO (statutory test regulation): rapid antigen tests (a) performance indicators. Paul-Ehrlich-Institut. 2021;2\u20134."},{"key":"1284_CR14","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1038\/s41467-022-33460-0","volume":"13","author":"C Del Vecchio","year":"2022","unstructured":"Del Vecchio C, Cracknell Daniels B, Brancaccio G, Brazzale AR, Lavezzo E, Ciavarella C, et al. Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants. Nat Commun. 2022;13:5870. https:\/\/doi.org\/10.1038\/s41467-022-33460-0.","journal-title":"Nat Commun"},{"key":"1284_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/1354750X.2021.1876769","volume":"26","author":"M M\u00f6ckel","year":"2021","unstructured":"M\u00f6ckel M, Corman VM, Stegemann MS, Hofmann J, Stein A, Jones TC, et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers. 2021;26:213\u201320. https:\/\/doi.org\/10.1080\/1354750X.2021.1876769.","journal-title":"Biomarkers"},{"key":"1284_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/s22041620","author":"SM Yang","year":"2022","unstructured":"Yang SM, Lv S, Zhang W, Cui Y. Microfluidic point-of-care (POC) devices in early diagnosis: a review of opportunities and challenges. Sensors. 2022. https:\/\/doi.org\/10.3390\/s22041620.","journal-title":"Sensors"},{"key":"1284_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/mi13081238","author":"B Yin","year":"2022","unstructured":"Yin B, Wan X, Sohan ASMMF, Lin X. Microfluidics-based POCT for SARS-CoV-2 diagnostics. Micromachines. 2022. https:\/\/doi.org\/10.3390\/mi13081238.","journal-title":"Micromachines"},{"key":"1284_CR18","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2020-0125","author":"HJ Walker","year":"2020","unstructured":"Walker HJ, Burrell MM. Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19? Bioanalysis. 2020. https:\/\/doi.org\/10.4155\/bio-2020-0125.","journal-title":"Bioanalysis"},{"key":"1284_CR19","doi-asserted-by":"publisher","DOI":"10.1039\/c4an01100g","author":"R Cumeras","year":"2015","unstructured":"Cumeras R, Figueras E, Davis CE, Baumbach JI, Gr\u00e0cia I. Review on ion mobility spectrometry. Part 1: current instrumentation. Analyst. 2015. https:\/\/doi.org\/10.1039\/c4an01100g.","journal-title":"Analyst"},{"key":"1284_CR20","doi-asserted-by":"publisher","DOI":"10.1039\/c4an01101e","author":"R Cumeras","year":"2015","unstructured":"Cumeras R, Figueras E, Davis CE, Baumbach JI, Gr\u00e0cia I. Review on ion mobility spectrometry. Part 2: hyphenated methods and effects of experimental parameters. Analyst. 2015. https:\/\/doi.org\/10.1039\/c4an01101e.","journal-title":"Analyst"},{"key":"1284_CR21","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/3\/3\/036004","author":"W Vautz","year":"2009","unstructured":"Vautz W, Nolte J, Fobbe R, Baumbach JI. Breath analysis\u2014Performance and potential of ion mobility spectrometry. J Breath Res. 2009. https:\/\/doi.org\/10.1088\/1752-7155\/3\/3\/036004.","journal-title":"J Breath Res"},{"key":"1284_CR22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-anchem-071213-020043","author":"A Amann","year":"2014","unstructured":"Amann A, Miekisch W, Schubert J, Buszewski B, Ligor T, Jezierski T, et al. Analysis of exhaled breath for disease detection. Annu Rev Anal Chem. 2014. https:\/\/doi.org\/10.1146\/annurev-anchem-071213-020043.","journal-title":"Annu Rev Anal Chem"},{"key":"1284_CR23","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/8\/3\/037110","author":"M Schivo","year":"2014","unstructured":"Schivo M, Aksenov AA, Linderholm AL, McCartney MM, Simmons J, Harper RW, et al. Volatile emanations from in vitro airway cells infected with human rhinovirus. J Breath Res. 2014. https:\/\/doi.org\/10.1088\/1752-7155\/8\/3\/037110.","journal-title":"J Breath Res"},{"key":"1284_CR24","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/cbic.201300695","volume":"15","author":"AA Aksenov","year":"2014","unstructured":"Aksenov AA, Sandrock CE, Zhao W, Sankaran S, Schivo M, Harper R, et al. Cellular scent of influenza virus infection. ChemBioChem. 2014;15:1040\u20138. https:\/\/doi.org\/10.1002\/cbic.201300695.","journal-title":"ChemBioChem"},{"key":"1284_CR25","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/aa9eef","author":"G Purcaro","year":"2018","unstructured":"Purcaro G, Rees CA, Wieland-Alter WF, Schneider MJ, Wang X, Stefanuto PH, et al. Volatile fingerprinting of human respiratory viruses from cell culture. J Breath Res. 2018. https:\/\/doi.org\/10.1088\/1752-7163\/aa9eef.","journal-title":"J Breath Res"},{"key":"1284_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003311","author":"LDJ Bos","year":"2013","unstructured":"Bos LDJ, Sterk PJ, Schultz MJ. Volatile metabolites of pathogens: a systematic review. PLoS Pathog. 2013. https:\/\/doi.org\/10.1371\/journal.ppat.1003311.","journal-title":"PLoS Pathog"},{"key":"1284_CR27","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/ab9c32","author":"O Gould","year":"2020","unstructured":"Gould O, Ratcliffe N, Kr\u00f3l E, De Lacy Costello B. Breath analysis for detection of viral infection, the current position of the field. J Breath Res. 2020. https:\/\/doi.org\/10.1088\/1752-7163\/ab9c32.","journal-title":"J Breath Res"},{"key":"1284_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99742-7","author":"M Feuerherd","year":"2021","unstructured":"Feuerherd M, Sippel AK, Erber J, Baumbach JI, Schmid RM, Protzer U, et al. A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-99742-7.","journal-title":"Sci Rep"},{"key":"1284_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.21.20136523","author":"H Chen","year":"2020","unstructured":"Chen H, Qi X, Ma J, Zhang C, Feng H, Yao M. Breath-borne VOC biomarkers for COVID-19. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.06.21.20136523.","journal-title":"medRxiv"},{"key":"1284_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100609","author":"DM Ruszkiewicz","year":"2020","unstructured":"Ruszkiewicz DM, Sanders D, O\u2019Brien R, Hempel F, Reed MJ, Riepe AC, et al. Diagnosis of COVID-19 by analysis of breath with gas chromatography-ion mobility spectrometry\u2014a feasibility study. EClinicalMedicine. 2020. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100609.","journal-title":"EClinicalMedicine"},{"key":"1284_CR31","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7163\/abe5ca","author":"C Steppert","year":"2021","unstructured":"Steppert C, Steppert I, Sterlacci W, Bollinger T. Rapid detection of SARS-CoV-2 infection by multicapillary column coupled ion mobility spectrometry (MCC-IMS) of breath. A proof of concept study. J Breath Res. 2021. https:\/\/doi.org\/10.1088\/1752-7163\/abe5ca.","journal-title":"J Breath Res"},{"key":"1284_CR32","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00139-2021","author":"W Ibrahim","year":"2021","unstructured":"Ibrahim W, Cordell RL, Wilde MJ, Richardson M, Carr L, Sundari Devi Dasi A, et al. Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography\u2013mass spectrometry. ERJ Open Res. 2021. https:\/\/doi.org\/10.1183\/23120541.00139-2021.","journal-title":"ERJ Open Res"},{"key":"1284_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103154","author":"S Grassin-Delyle","year":"2021","unstructured":"Grassin-Delyle S, Roquencourt C, Moine P, Saffroy G, Carn S, Heming N, et al. Metabolomics of exhaled breath in critically ill COVID-19 patients: a pilot study. EBioMedicine. 2021. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103154.","journal-title":"EBioMedicine"},{"key":"1284_CR34","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1021\/acsnano.0c05657","volume":"14","author":"B Shan","year":"2020","unstructured":"Shan B, Broza YY, Li W, Wang Y, Wu S, Liu Z, et al. Multiplexed nanomaterial-based sensor array for detection of COVID-19 in exhaled breath. ACS Nano. 2020;14:12125\u201332. https:\/\/doi.org\/10.1021\/acsnano.0c05657.","journal-title":"ACS Nano"},{"key":"1284_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-020-08169-0","author":"AGWE Wintjens","year":"2020","unstructured":"Wintjens AGWE, Hintzen KFH, Engelen SME, Lubbers T, Savelkoul PHM, Wesseling G, et al. Applying the electronic nose for pre-operative SARS-CoV-2 screening. Surg Endosc. 2020. https:\/\/doi.org\/10.1007\/s00464-020-08169-0.","journal-title":"Surg Endosc"},{"key":"1284_CR36","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2021.203.1_meetingabstracts.a3768","author":"R de Vries","year":"2021","unstructured":"de Vries R, Vigeveno RM, Mulder S, Farzan N, Vintges DR, Goeman JJ, et al. Ruling out SARS-CoV-2 infeciton using exhaled breath analysis by electronic nose in a public health setting. medRxiv. 2021. https:\/\/doi.org\/10.1164\/ajrccm-conference.2021.203.1_meetingabstracts.a3768.","journal-title":"medRxiv"},{"key":"1284_CR37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.5829\/idosi.wasj.2013.21.8.2913","volume":"21","author":"UB Baizyldayeva","year":"2013","unstructured":"Baizyldayeva UB, Uskenbayeva RK, Amanzholova ST. Decision making procedure: applications of IBM SPSS cluster analysis and decision tree. World Appl Sci J. 2013;21:1207\u201312. https:\/\/doi.org\/10.5829\/idosi.wasj.2013.21.8.2913.","journal-title":"World Appl Sci J"},{"key":"1284_CR38","first-page":"1","volume-title":"Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR: a guide for health protection teams","author":"Public Health England","year":"2020","unstructured":"Public Health England. Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR: a guide for health protection teams. Public Heal Engl; 2020. p. 1\u201312."},{"key":"1284_CR39","unstructured":"RKI\u2014Coronavirus SARS-CoV-2\u2014Empfehlungen zu Isolierung und Quarant\u00e4ne bei SARS-CoV-2-Infektion und -Exposition, Stand 2.5.2022. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Quarantaene\/Absonderung.html;jsessionid=1FC86EBE9E72AA0888DD33D7C7E5F806.internet082?nn=13490888. Accessed 26 May 2022."},{"key":"1284_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115589","author":"AD Subali","year":"2022","unstructured":"Subali AD, Wiyono L, Yusuf M, Zaky MFA. The potential of volatile organic compounds-based breath analysis for COVID-19 screening: a systematic review & meta-analysis. Diagn Microbiol Infect Dis. 2022. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115589.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1284_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-022-00661-2","volume":"5","author":"DK Nurputra","year":"2022","unstructured":"Nurputra DK, Kusumaatmaja A, Hakim MS, Hidayat SN, Julian T, Sumanto B, et al. Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition. NPJ Digit Med. 2022;5:1\u201317. https:\/\/doi.org\/10.1038\/s41746-022-00661-2.","journal-title":"NPJ Digit Med"},{"key":"1284_CR42","doi-asserted-by":"publisher","DOI":"10.3346\/JKMS.2020.35.E174","author":"Y Lee","year":"2020","unstructured":"Lee Y, Min P, Lee S, Kim SW. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020. https:\/\/doi.org\/10.3346\/JKMS.2020.35.E174.","journal-title":"J Korean Med Sci"},{"key":"1284_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0016-5","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Quackenbush J, Schwartz LH, Aerts HJWL. Artificial intelligence in radiology. Nat Rev Cancer. 2018. https:\/\/doi.org\/10.1038\/s41568-018-0016-5.","journal-title":"Nat Rev Cancer"},{"key":"1284_CR44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s42256-021-00337-8","volume":"3","author":"G Kaissis","year":"2021","unstructured":"Kaissis G, Ziller A, Passerat-Palmbach J, Ryffel T, Usynin D, Trask A, et al. End-to-end privacy preserving deep learning on multi-institutional medical imaging. Nat Mach Intell. 2021;3:473\u201384. https:\/\/doi.org\/10.1038\/s42256-021-00337-8.","journal-title":"Nat Mach Intell"},{"key":"1284_CR45","first-page":"1","volume":"2","author":"Robert Koch Institut","year":"2021","unstructured":"Robert Koch Institut. Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland. Robert Koch Inst. 2021;2:1\u201319.","journal-title":"Robert Koch Inst"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01284-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01284-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01284-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T13:06:08Z","timestamp":1700571968000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01284-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01284-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Munich, Germany (approval no. 437\/20 S-KH) and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FV reports personal fees, non-financial support from Gilead Sciences, and grants from MSD outside the submitted work. The institution of E.D.W., R.S., and W.B. received Funding from Inflammatix, Gentian, and B. Braun Melsungen. JS reports grants, personal fees, and non-financial support from AbbVie, Gilead, Janssen, and Dr. Falk GmbH. UP received personal fees from Abbott, Abbvie, Arbutus, Gilead, GSK, J&J, MSD, Roche, Sanofi, Sobi, and Vaccitech. UP is co-founder and shareholder of SCG Cell Therapy. The UP laboratory received grants from Hoenle AG and SCG Cell Therapy. The State of Bavaria supported the project via research networks FOR-COVID and Bay-VOC, by the project \u201cVirological and immunological determinants of COVID-19 pathogenesis\u2014lessons to get prepared for future pandemics (KA1-Co-02 \u201cCOVIPA\u201d),\u201d a grant from the Helmholtz Association's Initiative and Networking Fund, by the European Commission FET Open Grant VIROFIGHT (Grant No. 899619). CS reports grants and personal fees from AstraZeneca; personal fees and non-financial support from B. Braun Melsungen; personal fees from BioNTech; grants, personal fees, and non-financial support from Gilead Sciences; grants and personal fees from Janssen-Cilag; personal fees from Eli Lilly; personal fees from Formycon; personal fees from Pfizer; personal fees from Roche; other from Apeiron; grants and personal fees from MSD; grants from Cepheid; personal fees from GSK; personal fees from molecular partners; other from Eli Lilly; personal fees from SOBI during the conduct of the study; personal fees from AbbVie; personal fees from MSD; personal fees from Synairgen; and grants and personal fees from ViiV Healthcare outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}